Correlation Engine 2.0
Clear Search sequence regions

  • antitumor (1)
  • hematopoiesis (1)
  • hemopoiesis (2)
  • humans (1)
  • marrow (1)
  • myeloma (1)
  • Sizes of these terms reflect their relevance to your search.

    Several neurotransmitters and neuropeptides were reported to join in or cooperate with different cells of the immune system, bone marrow, and peripheral cells. Numerous data support that neuroactive molecules might control immune system activity and hemopoiesis operating on lymphoid organs and the primary hematopoietic unit, the hematopoietic niche. Furthermore, many compounds seem to be able to take part in the leukemogenesis and lymphomagenesis process and in the onset of multiple myeloma. In this review, we will assess the possibility that neurotransmitters and neuropeptides may have a role in the onset of haematological neoplasms, may affect the response to treatment, or may represent a useful starting point for a new therapeutic approach. More in vivo investigations are needed to evaluate neuropeptide's role in haematological malignancies and their possible utilization as an antitumor therapeutic target. Comprehending the effect of the pharmacological administration of neuropeptide modulators on hematologic malignancies opens up new possibilities in curing clonal hematologic diseases to achieve more satisfactory outcomes. Copyright© Bentham Science Publishers; For any queries, please email at


    Alessandro Allegra, Emanuela Sant'Antonio, Caterina Musolino, Roberta Ettari. New Insights into Neuropeptides Regulation of the Immune System and Hemopoiesis: Effects on Hematologic Malignancies. Current medicinal chemistry. 2022;29(14):2412-2437

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34521320

    View Full Text